Cargando…
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
BACKGROUND: High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat these two aggressive cancers successfully centers on the fact that while the majority of patients are diagnosed based on current surveillance...
Autores principales: | Pereira, Elena, Camacho-Vanegas, Olga, Anand, Sanya, Sebra, Robert, Catalina Camacho, Sandra, Garnar-Wortzel, Leopold, Nair, Navya, Moshier, Erin, Wooten, Melissa, Uzilov, Andrew, Chen, Rong, Prasad-Hayes, Monica, Zakashansky, Konstantin, Beddoe, Ann Marie, Schadt, Eric, Dottino, Peter, Martignetti, John A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696808/ https://www.ncbi.nlm.nih.gov/pubmed/26717006 http://dx.doi.org/10.1371/journal.pone.0145754 |
Ejemplares similares
-
Outcomes of gynecologic oncology patients at an epicenter of the COVID-19 pandemic
por: Carr, Caitlin, et al.
Publicado: (2021) -
Detection of endometrial precancer by a targeted gynecologic cancer liquid biopsy
por: Martignetti, John A., et al.
Publicado: (2018) -
Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression
por: Agnani, Deep, et al.
Publicado: (2011) -
Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study
por: Nair, Navya, et al.
Publicado: (2016) -
Rapid development and use of patient-specific ctDNA biomarkers to avoid a “rash decision” in an ovarian cancer patient
por: Pandya, Deep, et al.
Publicado: (2019)